| 血管生成抑制剂与肺癌治疗的研究进展 |
| |
| 引用本文： | 赖泳,刘光明.血管生成抑制剂与肺癌治疗的研究进展[J].大理学院学报,2007,6(6):58-60. |
| |
| 作者姓名： | 赖泳 刘光明 |
| |
| 作者单位： | 大理学院药学院,云南大理,671000 |
| |
| 摘 要： | 目的:探讨血管生成抑制剂治疗肺癌的研究进展.方法:收集该类药物的国内外近期资料加以综合归纳.结果:血管生成抑制剂治疗肺癌方法可行,前景诱人.结论:随着血管生成抑制剂的不断开发和研究,对于肺癌这一血管增生明显的肿瘤,深入研究抗血管治疗具有重要意义.
|
| 关 键 词： | 肺癌 血管生成 抑制剂 |
| 文章编号： | 1672-2345（2007）06-0058-03 |
| 修稿时间： | 2007-05-07 |
Progress of treatment of lung cancer with angiogenesis inhibitors |
| |
| LAI Yong,LIU Guang-ming.Progress of treatment of lung cancer with angiogenesis inhibitors[J].Journal of Dali University,2007,6(6):58-60. |
| |
| Authors: | LAI Yong LIU Guang-ming |
| |
| Institution: | College of Pharmacy, Dali University, Dali, Yunnan 671000, China |
| |
| Abstract: | objective: To discuss the progress angiogenesis inhibitors on treatment of lung cancer.Methods: Collecting and summarizing domestic and foreign data concerned recently.Results: Angiogenesis inhibitors have brighter prospects on treatment of lung cancers.Conclusion: Along with the investigation and exploitation of angiogenesis inhibitors,further research into treatments of antiangiogenesis takes on significant value for lung cancer that is characterized by obvious hyperplasia of blood vessel. |
| |
| Keywords: | lung cancer angiogenesis inhibitor |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
